LFCR
Lifecore Biomedical Inc.
6.50$
+0.2%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -121.1% | – | -107.4% | – | – | +345.6% | -67.0% | – | – | -146.6% | – | |
| – | -18.5% | +63.8% | -22.2% | -11.5% | +2.6% | +1.6% | -7.9% | +3.6% | – | – | +8.9% | – | |
| – | +2.9% | -48.3% | +95.8% | +51.4% | +39.4% | -24.3% | -28.9% | +31.8% | – | – | +22.8% | – | |
| – | – | +631.6% | -21.2% | +64.0% | -216.5% | – | – | – | – | – | -255.7% | – | |
| – | -15.7% | +115.0% | -71.2% | +28.6% | -27.2% | +120.9% | -61.6% | -17.2% | -100.0% | – | -54.1% | – | |
| – | – | – | -67.7% | +28.6% | -27.2% | – | -235.8% | -17.2% | – | – | – | – | |
| – | – | – | – | +7.8% | – | – | – | – | – | – | – | – | |
| – | – | – | – | +1,302.4% | – | – | – | – | – | – | -68.4% | – | |
| – | – | – | – | – | -750.8% | -43.0% | -96.3% | +0.4% | – | – | – | – | |
| – | -183.4% | – | -102.5% | – | +1,045.0% | -154.2% | -94.1% | +245.3% | – | – | +1,209.4% | – | |
| – | – | – | -66.6% | -154.6% | – | -202.6% | – | -147.9% | – | – | +118.6% | – | |
| – | – | – | – | -167.2% | – | – | – | -99.2% | – | – | -175.4% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.